Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke

NCT02089464 is registered in ClinicalTrials.gov with Nexstim Ltd as lead sponsor.

NCT NCT02089464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02089464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Phase III, Prospective, Multicenter, Double Blinded, Randomized, Sham Controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 Hz rTMS Administered to the Contralesional Hemisphere as Adjuvant to Task Oriented Rehabilitation in Patients With Ischemic or Hemorrhagic Stroke
Lead sponsor
Nexstim Ltd
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2014
Completion date
May 31, 2016
Enrollment
199 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

stroke